Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315516) titled 'Sleep and Stress Study' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: RDC Clinical Pty Ltd
Condition:
Sleep Disorder (Disorder)
Stress
Anxiety
Intervention:
Dietary Supplement: Lavender Oil
Dietary Supplement: Palmitoylethanolamide (PEA)
Dietary Supplement: Oleoylethanolamide
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: February 2026
Target Sample Size: 240
Countries of ...